Database Chem. Abstr. (Columbus, OH, USA) Abstract No. 120:153730, Heuer, H. ‘Synergistic Combinations of PAF antagonists and anticholinerigic agents as drugs for treatment of bronchial asthma’, abstrct, DE 4219659 A1, Dec. 23, 1993. |
Arch. int. Pharmacodyn., 1965, 156, No. 2 pp. 467-488; P.M. Lish et al.; “Oxybutynin—A Musculotropic Antispasmodic Drug with Moderate Anticholinergic Action”. |
The Journal of Pharm. and Experimental Therapeutics; vol. 256, No. 2; pp. 562-567; L. Noronha-Blob, et al.; “Enantiomers of Oxybutynin: In Vitro Pharmacological Characterization at M1,M2 and M3 Muscarinic Receptors and in Vivo Effects on Urinary Bladder Contraction, Mydriasis and Salivary Secretion in Guinea Pigs”. (1991). |
The Journal of Pharm. and Experimental Therapeutics; vol. 247, No. 3; pp. 867-872; Kachur, et al.; “R and S Enantiomers of Oxybutynin: Pharmacological Effects in Guinea Pig Bladder and Intestine” (1991). |
The Journal of Urology; vol. 148, 595-597, Aug. 1992; Massad, et al.; “The Pharmacokinetics of Intravesical and Oral Oxygutynin Chloride”. |
Eur J. Clin Pharmacol (1988) 35: 515-520; Douchamps et al.; “The Pharmacokinetics of Oxybutynin in Man”. |
Drug Development Research 8:37-51 (1986); Meuldermans, et al.; “Excretion and Biotransformation of Astemizole in Rats, Guinea-Pigs, Dogs, and Man”. |
The Canadian Journal of Hospital Pharmacy—vol. 45, No. 1, Feb., 1992; pp. 33-37; “Astemizole and Terfenadine-Induced Cardiovascular Effects”. |
Arzneim-Forsch/Drug. Res. 41 (11), Nr. 9 (1991); Kamei, et al.; “Antiallergic Effects of Major Metabolites of Astemizole in Rats and Guinea Pigs”. |
Chem. Pharm. Bull. 40(6) 1415-1423 (1992); Take, et al.; “Agents for the Treatment of Overactive Detrusor. III. Synthesis and Structure-Activity Relationships of N-(4-Amino-2-butynyl)acetamide Derivatives”. |
J.Med. Chem. 1991, 34, 3065-3074; Carter et al.; “Analogues of Oxybutynin. Synthesis and Antimuscarinic and Bladder Activity of Some Substituted 7-Amino-1-hydroxy-5-heptyn-2-ones and Related Compounds”. |
Xenobiotica, 1992, vol. 22, No. 7, 859-869; Hughes, et al.; “Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers.” |
Acta Pharmacol. et toxicol. 1984, 55-100-103; Aaltonen, et al.; “Antimuscarinic Activity of Oxybutynin in the Human Plasma Quantitated by a Radioreceptor Assay”. |
Acta Pharm. Suec. 18, 25-34 (1981); Lindeke, et al.; “Determination of oxybutynin (4-diethylaminobut-2-ynyl 2-cyclohexyl-2-phenylglycolate) in serum and urine by gas chromatography/mass spectrometry with single ion detection”. |
Biomedical Mass Spectrometry, vol. 8, No. 10, 1981; pp. 506-513; “Metabolism of Oxybutnin: Establishment of Desethyloxybutynin and Oxybutynin N-Oxide Formation in Rat Liver Preparations Using Deuterium Substition and Gas Chromatographic Mass Spectrometric Analysis”. |
J.Med.Chem. 1991, 34, 3065-3074; Carter et al.; “Analogues of Oxybutynin. Synthesis and Antimuscarinic and Bladder Activity of Some Substituted 7-Amino-1-hydroxy-5-heptyn-2-ones and Related Compounds”. |
Chem.Pharm. Bull 40(6) 1415-1423 (1992); Take et al.; “Agents for the treatment of Overactive Detrusor.III. Synthesis and Structure-Activity Relationships of N-(4-Amino-2-butynyl)acetamide Derivatives”. |
Arch.int.Pharmacodyn., 1965, 156, No. 2; 467-488; Lish et al.; “Oxybutynin—A Musculotropic Antispasmodic Drug with Moderate Anticholinerigic Actions”. |